Pulse ·
Pre-eclampsia raises CKD risk up to 15-fold — new cohort study
A Danish population cohort study of 286,078 pregnancies published in BJOG found that women who had pre-eclampsia face significantly elevated long-term kidney disease risk. Those with moderate to severe proteinuria during the episode had a 15.5-fold higher adjusted risk of chronic kidney disease at 10 years. Even pre-eclampsia with minimal proteinuria carried a three-fold risk increase.
Pre-eclampsia is now understood as a cardiovascular and renal sentinel event, not only an obstetric complication. Post-natal follow-up for blood pressure and kidney function should be standard care for women who experienced it.
What just happened
Australian Doctor reported today on a large Danish population cohort study — 286,078 pregnancies, followed for up to two decades — that quantifies just how significant the long-term kidney impact of pre-eclampsia is, and how much it scales with the severity of protein leakage during the episode.
The study, published in BJOG: An International Journal of Obstetrics and Gynaecology, was led by Aarhus University Hospital and used routinely collected national data from Danish medical registries covering pregnancies between 1998 and 2018, with follow-up through 2021. Of the cohort, 9,538 women (3.3%) had pre-eclampsia.
The headline finding: women who had pre-eclampsia with moderate to severe urinary protein excretion had a 15.5-fold higher adjusted hazard ratio for developing chronic kidney disease (CKD) at 10 years — compared to women who had no pre-eclampsia at all. Women whose pre-eclampsia involved no or minimal proteinuria still carried a three-fold higher CKD risk at 10 years.
The study also found elevated rates of hypertension (up to 5.6-fold) and cardiovascular disease (up to 2.2-fold) in the moderate-to-severe proteinuria group.
The both-and
Pre-eclampsia has always been understood as a pregnancy problem
The traditional framing of pre-eclampsia is obstetric: a condition of the second half of pregnancy, defined by elevated blood pressure and proteinuria, that resolves after delivery. The focus of clinical attention is on the immediate pregnancy and birth risks — premature delivery, placental abruption, eclamptic seizures, foetal growth restriction. Those risks are real, the management is well-established, and the monitoring during pregnancy is appropriate.
What has been underweighted in clinical practice is what happens to the blood vessels and kidneys of the woman after the pregnancy ends.
Pre-eclampsia is now understood in the research literature as a window onto systemic vascular and renal health — not a condition that disappears at delivery but a marker of underlying endothelial dysfunction that predisposes to long-term cardiovascular and renal disease. Renal and Urology News has covered the accumulating evidence base. The Danish study is among the largest and most methodologically rigorous additions to that literature.
The proteinuria gradient matters
The study’s most actionable finding is the dose-response relationship between proteinuria severity during pre-eclampsia and subsequent kidney disease risk. The 15.5-fold hazard ratio for CKD in women with moderate-to-severe proteinuria is not a marginal statistical signal. It represents a group of women whose long-term kidney health requires active monitoring, not a box-ticked discharge note at six weeks postpartum.
The mechanisms are not fully elucidated, but the working hypothesis is that severe pre-eclampsia reflects more significant vascular injury to the glomerular capillaries during the episode. Some of that injury resolves; some may leave subclinical scarring that, under the pressure of ageing, other diseases, or subsequent pregnancies, eventually crosses the threshold for clinical CKD.
Women in their 40s who had pre-eclampsia in their 20s or 30s are precisely in this follow-up window. The ten-year cumulative incidence risk identified in the Danish data (CKD in 5.0% of those with moderate-to-severe proteinuria, compared to 1.1% with no or mild proteinuria, and baseline population rates lower still) translates to real numbers of women who may be developing kidney disease without any connection being made to their obstetric history.
What Australian postnatal care typically provides
Australian postnatal care guidelines recommend a follow-up blood pressure check at six weeks for women who had pre-eclampsia, and ongoing hypertension management if blood pressure remains elevated. What is less systematically embedded is longer-term renal surveillance — an annual urine albumin-creatinine ratio and eGFR — for women who had pre-eclampsia with significant proteinuria.
This is not a criticism of general practice. It is a reflection of the evidence maturing. The Danish data strengthens the case for making renal follow-up a standing part of postnatal care for this group.
2 cents
If you had pre-eclampsia during a pregnancy — particularly if you were told the protein in your urine was significant — your kidney health is worth monitoring on an ongoing basis, not just in the weeks after delivery.
The practical questions for your next general practice appointment: Has your GP recorded your obstetric history, including pre-eclampsia? When did you last have a urine albumin-creatinine ratio and kidney function test? If you have high blood pressure now, is the treating clinician aware of your pre-eclampsia history?
These questions do not require a specialist referral to answer. They are standard investigations your GP can order as part of a routine health check. The obstetric history is the relevant flag — it tells your GP which investigations to prioritise and at what frequency.
If you had pre-eclampsia more than five years ago and have not had kidney function or urine protein checked in that time, raising it at your next appointment is a proportionate and evidence-supported step.
Verdict: yes — a large, well-designed study that should update how GPs track women with a pre-eclampsia history for long-term kidney and cardiovascular risk.
Sources cited
- Australian Doctor — Higher urinary protein excretion foreshadows CKD risk in women with pre-eclampsia. 8 July 2026. https://www.ausdoc.com.au/news/higher-urinary-protein-excretion-foreshadows-ckd-risk-in-women-with-pre-eclampsia-study-suggests/
- BJOG — Vestergaard AHS et al. Pre-eclampsia and later maternal kidney and cardiovascular outcomes. Published online 19 May 2026. https://obgyn.onlinelibrary.wiley.com/journal/14710528
- Renal and Urology News — Women with preeclampsia have increased risk of later hypertension, CKD. https://www.renalandurologynews.com/news/women-with-preeclampsia-have-increased-risk-of-later-hypertension-ckd/
Frequently asked questions
-
I had pre-eclampsia during pregnancy. What should I be asking my GP about now?
Women who experienced pre-eclampsia should have their blood pressure monitored regularly and ideally have an annual kidney function check (eGFR and urine albumin-creatinine ratio) and fasting lipid and glucose panel. How long ago the pregnancy was does not reduce the relevance of follow-up — the Danish cohort found elevated risk at 10 years. If you have not had a postnatal cardiovascular and renal review, asking your GP to set one up is a reasonable and evidence-supported request.
-
What is proteinuria and why does it matter for long-term kidney risk?
Proteinuria means protein is leaking into the urine from the kidneys — a sign that the kidney's filtration barrier has been stressed or damaged. In the context of pre-eclampsia, higher levels of proteinuria during the episode signal more significant kidney involvement. The Danish study found that women with moderate or severe proteinuria during pre-eclampsia had a 15.5-fold increased risk of chronic kidney disease at 10 years, compared to a three-fold increase for women whose pre-eclampsia did not involve significant proteinuria.